About this episode

Chadi Nabhan discusses the evolving role of next-generation sequencing in cancer with Ezra Cohen.

Chadi sits down with Ezra Cohen, MD, Chief Medical Officer of Oncology at Tempus AI, for an in-depth discussion on the evolving role of next-generation sequencing (NGS) across the cancer continuum. Together, they explore how tissue-based testing, liquid biopsy, and measurable residual disease (MRD) assessments are reshaping precision oncology, why NGS remains underutilized in many patients, and the educational efforts needed to ensure genomic testing is ordered and applied appropriately to im...

People in this episode

Host: Chadi Nabhan

Guest: Ezra Cohen

Topics covered

• next-generation sequencing
• cancer
• precision oncology
• liquid biopsy
• measurable residual disease
• genomic testing

Keywords

• NGS
• cancer continuum
• tissue-based testing
• liquid biopsy
• MRD assessments
• precision oncology
• genomic testing

Mentioned in this episode

Organizations: Tempus AI, Oncology

More episodes of Healthcare Unfiltered

• Episode 288 - Leadership Lessons: From Bunker Hill to the Boardroom · July 21, 2026 · 53 min
• Episode 287 - RAS in Pancreatic Cancer: The RASolute 302 Study · July 14, 2026 · 39 min
• LOS DIFERENTES SIGNIFICADOS DE LA PALABRA CÁNCER EN HEMATOLOGÍA · July 1, 2026 · 44 min
• Episode 285 - Gabby’s Journey: Cancer, Hope, and Resilience · June 30, 2026 · 47 min
• Episode 284: The Evolution of Liver Transplant for Cancer With Maen Abdelrahim · June 23, 2026 · 39 min
• Episode 283 - MAID in America: Navigating Choice, Compassion, and Controversy · June 16, 2026 · 51 min

Explore listener stats, chart rankings, contacts and more on the Healthcare Unfiltered podcast page.